Higher dose of new antimalarial drug reduces disease recurrence by 85%

AI nuclear energy background, future innovation of disruptive technology

A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published today in eLife.

When does mental distress become a mental illness?

Previous article

Following insect ‘footprints’ to improve crop resilience and monitor pollinator biodiversity

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News